Aude Béranger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aude Béranger has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Bianca Colonna
Department of Biology and Biotechnology “C. Darwin”, Istituto Pasteur Italia, Sapienza Università di Roma, Rome, Italy
1 shared publication - Francesco Zanzi
Institute of Translational Pharmacology, Council of National Research, Rome, Italy
1 shared publication - Gianni Prosseda
Institute Pasteur Italia, Department of Biology and Biotechnologies “Charles Darwin”, Sapienza University of Rome, Rome, Italy
1 shared publication - Giulia Fanelli
Istituto Pasteur Italia, Dipartimento di Biologia e Biotecnologie “C. Darwin”, Sapienza Università di Roma, Via dei Sardi 70, 00185 Rome, Italy
1 shared publication - Marco Coluccia
Sapienza University of Rome
1 shared publication - Martina Pasqua
Istituto Pasteur Italia, Dipartimento di Biologia e Biotecnologie “C. Darwin”, Sapienza Università di Roma, Via dei Sardi 70, 00185 Rome, Italy
1 shared publication
Latest Publications
- Open Access
- 11 May 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (5) , 823
Role of the MDR Efflux Pump AcrAB in Epithelial Cell Invasion by Shigella flexneri
The tripartite complex AcrAB-TolC is the major RND pump in Escherichia coli and other Enterobacteriaceae, including Shigella, the etiological agent of bacillary dysentery. In addition to conferring resistance to many classes of antibiotics, AcrAB plays a role in the pathogenesis and virulence of several bacterial pathogens. Here, we report data demonstrating that AcrAB specifically contributes to Shigella flexneri invasion of epithelial cells. We found that deletion of both acrA and acrB genes causes reduced survival of S. flexneri M90T strain within Caco-2 epithelial cells and prevents cell-to-cell spread of the bacteria. Infections with single deletion mutant strains indicate that both AcrA and AcrB favor the viability of the intracellular bacteria. Finally, we were able to further confirm the requirement of the AcrB transporter activity for intraepithelial survival by using a specific EP inhibitor. Overall, the data from the present study expand the role of the AcrAB pump to an important human pathogen, such as Shigella, and add insights into the mechanism governing the Shigella infection process.
- 11 May 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (5) , 823
Open AccessRole of the MDR Efflux Pump AcrAB in Epithelial Cell Invasion by Shigella flexneri
The tripartite complex AcrAB-TolC is the major RND pump in Escherichia coli and other Enterobacteriaceae, including Shigella, the etiological agent of bacillary dysentery. In addition to conferring resistance to many classes of antibiotics, AcrAB plays a role in the pathogenesis and virulence of several bacterial pathogens. Here, we report data demonstrating that AcrAB specifically contributes to Shigella flexneri invasion of epithelial cells. We found that deletion of both acrA and acrB genes causes reduced survival of S. flexneri M90T strain within Caco-2 epithelial cells and prevents cell-to-cell spread of the bacteria. Infections with single deletion mutant strains indicate that both AcrA and AcrB favor the viability of the intracellular bacteria. Finally, we were able to further confirm the requirement of the AcrB transporter activity for intraepithelial survival by using a specific EP inhibitor. Overall, the data from the present study expand the role of the AcrAB pump to an important human pathogen, such as Shigella, and add insights into the mechanism governing the Shigella infection process.